Incidence of the ASXL1 gene in myeloid panel testing of AML and MDS patients

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKarakoyun, Hilal
dc.contributor.authorYirmibes, Seren
dc.contributor.authorMilas, Ceyda
dc.contributor.authorYararbas, Kanay
dc.contributor.authorSahin, Deniz Goren
dc.contributor.authorSayar, Ceyhan
dc.contributor.authorYucel, Yazgi
dc.contributor.authorArat, Mutlu
dc.date.accessioned2025-10-16T15:13:59Z
dc.date.issued2024
dc.description.abstract56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, SCOTLAND, JUN 10-13, 2023
dc.identifier.otherWOS:001147414901118
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6020
dc.publisherSPRINGERNATURE
dc.sourceEUROPEAN JOURNAL OF HUMAN GENETICS
dc.titleIncidence of the ASXL1 gene in myeloid panel testing of AML and MDS patients
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS